Results 171 to 180 of about 4,942 (259)

New therapeutic options for lowering LDL cholesterol [PDF]

Jurković Dubravčić, Nikolina, Mixich, Renee, Pejković, Senka   +2 more
core   +2 more sources

Patients' perceptions on the facilitators and barriers using injectable therapies in dyslipidaemia: An empirical qualitative descriptive international study [PDF]

, 2023
0000-0001-6385-8600, 0000-0001-8220-8347, 0000-0002-1985-3068, 0000-0002-2633-0871, 0000-0003-4673-7473, Baker, Edward E., Caggianelli, Gabriele, Dellafiore, Federica, Durante, Angela, Khan, Mutiba, Khatib, Rani, Lee, Geraldine A., Vellone, Ercole   +12 more
core   +1 more source

Determinants of circulating PCSK9 levels and the efficacy of PCSK9 inhibitor therapies in chronic kidney disease: a systematic review. [PDF]

Eur J Clin Pharmacol
Ábel T, Benczúr B, Csajbókné ÉC.
europepmc   +1 more source

PD11 Cost-Effectiveness Analysis Of Inclisiran For Treating Primary Hypercholesterolemia And Mixed Dyslipidemia In Singapore [PDF]

Young‐Hee Lim, Ru‐San Tan, Kian Keong Poh, Xiao Jun Wang   +3 more
openalex   +1 more source

Fair pricing, fair access; a systematic review of cost-effectiveness of new hyperlipidemia injectable medication in developing countries. [PDF]

Cost Eff Resour Alloc
Azari S, Pourasghari H, Rezaei MA, Behzadifar M, Salehbeigi S, Rajaei S, Jafarzadeh D, Soleimanpour S, Tajdini M.   +8 more
europepmc   +1 more source

Faculty Opinions recommendation of Long-term efficacy and safety of inclisiran in patients with high cardiovascular risk and elevated LDL cholesterol (ORION-3): results from the 4-year open-label extension of the ORION-1 trial.

, 2023
Joseph Proietto
openalex   +1 more source

Efficacy and safety of proprotein convertase subtilisin/kexin type 9 inhibitors for adults with familial hypercholesterolemia: A network meta-analysis. [PDF]

Int J Cardiol Cardiovasc Risk Prev
Ding W, Sun L, Shi Y, Tian L.
europepmc   +1 more source

Optimal Medical Therapy Targeting Lipids and Inflammation for Secondary Prevention in Patients Undergoing Percutaneous Coronary Intervention. [PDF]

J Clin Med
Forzano I, Florimonte D, Narciso V, Canonico ME, Castiello DS, Manzi L, Cristiano S, Spinelli A, Vallone DM, D'Alconzo D, Semplice F, Paolillo R, Giugliano G, Cesaro A, Gragnano F, Calabrò P, Esposito G, Gargiulo G.   +17 more
europepmc   +1 more source

Inclisiran. A New Kid on the New Block for Treating Hypercholesterolaemia

, 2020
Vasilios G. Athyros, Chrysoula Boutari, Κonstantinos Imprialos, Michael Doumas   +3 more
openalex   +1 more source

New opportunity for cholesterol lowering: inclisiran [PDF]

British Journal of Cardiology, 2021
openaire   +1 more source